NGF promotes cell cycle progression by regulating D-type cyclins via PI3K/Akt and MAPK/Erk activation in human corneal epithelial cells

Molecular Vision

Volumn 18, Issue , 2012, Pages 758-764

  Hong, Jiaxu ^a   Qian, Tingting ^a   Le, Qihua ^a   Sun, Xinghuai ^a   Wu, Jihong ^a   Chen, Junyi ^a   Yu, Xiaobo ^a   Xu, Jianjiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D; CYCLIN D1; CYCLIN D2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; RECOMBINANT NERVE GROWTH FACTOR; RECOMBINANT NERVE GROWTH FACTOR BETA SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVATION; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; WESTERN BLOTTING;

CELL CYCLE; CELL PROLIFERATION; CHROMONES; CORNEA; CYCLIN D; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MORPHOLINES; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84859457602     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Levi-Montalcini R. The nerve growth factor: its role in growth, differentiation and function of the sympathetic adrenergic neuron. Prog Brain Res 1976; 45:235-58.
2. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73:2424-8.
3. Chao MV. Neurotrophin receptors: a window into neuronal differentiation. Neuron 1992; 9:583-93.
4. Shooter EM. Early days of the nerve growth factor proteins. Annu Rev Neurosci 2001; 24:601-29.
5. Micera A, Lambiase A, Aloe L, Bonini S, Levi-Schaffer F. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev 2004; 15:411-7.
6. Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 2000; 41:1063-9.
7. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000; 107:1347-51.
8. Lambiase A, Bonini S, Micera A, Rama P, Aloe L. Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 1998; 39:1272-5.
9. Baum J. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. Surv Ophthalmol 1999; 43:372-3.
10. Esquenazi S, Bazan HE, Bui V, He J, Kim DB, Bazan NG. Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2005; 46:3121-7.
11. Qi H, Li DQ, Shine HD, Chen Z, Yoon KC, Jones DB, Pflugfelder SC. Nerve growth factor and its receptor TrkA serve as potential markers for human corneal epithelial progenitor cells. Exp Eye Res 2008; 86:34-40.
12. Caporali A, Emanueli C. Cardiovascular actions of neurotrophins. Physiol Rev 2009; 89:279-308.
13. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006; 361:1545-64.
14. Shanley LJ, McCaig CD, Forrester JV, Zhao M. Insulin, not leptin, promotes in vitro cell migration to heal monolayer wounds in human corneal epithelium. Invest Ophthalmol Vis Sci 2004; 45:1088-94.
15. Rajala MS, Rajala RV, Astley RA, Butt AL, Chodosh J. Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase/Akt activation. J Virol 2005; 79:12332-41.
16. Yang H, Wang Z, Capo-Aponte JE, Zhang F, Pan Z, Reinach PS. Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells. Exp Eye Res 2010; 91:462-71.
17. Romon R, Adriaenssens E, Lagadec C, Germain E, Hondermarck H, Le Bourhis X. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer 2010; 9:157.
18. Barouch R, Kazimirsky G, Appel E, Brodie C. Nerve growth factor regulates TNF-alpha production in mouse macrophages via MAP kinase activation. J Leukoc Biol 2001; 69:1019-26.
19. Obermeier A, Ahmed S, Manser E, Yen SC, Hall C, Lim L. PAK promotes morphological changes by acting upstream of Rac. EMBO J 1998; 17:4328-39.
20. Hamrah P, Cruzat A, Dastjerdi MH, Zheng L, Shahatit BM, Bayhan HA, Dana R, Pavan-Langston D. Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology 2010; 117:1930-6.
21. Kim EC, Lee WS, Kim MS. The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats. Invest Ophthalmol Vis Sci 2010; 51:4569-73.
22. Tang YCR. Relationship between the levels of nerve growth factor in tears and tear film stability after LASIK. Chinese Journal of Modern Eye Ear Nose and Throat 2007:1681-6412(2007)01-0014-03.
23. Lee BH, McLaren JW, Erie JC, Hodge DO, Bourne WM. Reinnervation in the cornea after LASIK. Invest Ophthalmol Vis Sci 2002; 43:3660-4.
24. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998; 338:1174-80.
25. Brewster WJ, Fernyhough P, Diemel LT, Mohiuddin L, Tomlinson DR. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 1994; 17:321-5.
26. Anand P, Pandya S, Ladiwala U, Singhal B, Sinicropi DV, Williams-Chestnut RE. Depletion of nerve growth factor in leprosy. Lancet 1994; 344:129-30.
27. Anand P. Nerve growth factor regulates nociception in human health and disease. Br J Anaesth 1995; 75:201-8.
28. Kruse FE, Tseng SC. Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 1993; 34:1963-76.
29. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296:1655-7.
30. Yan GZ, Ziff EB. Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J Neurosci 1997; 17:6122-32.
31. Marampon F, Casimiro MC, Fu M, Powell MJ, Popov VM, Lindsay J, Zani BM, Ciccarelli C, Watanabe G, Lee RJ, Pestell RG. Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB. Mol Biol Cell 2008; 19:2566-78.
32. Nguyen TX, Ahn JY. Lipase inactive mutant of PLC-gamma1 regulates NGF-induced neurite outgrowth via enzymatic activity and regulation of cell cycle regulatory proteins. J Biochem Mol Biol 2007; 40:888-94.
33. Kerr B, Garcia-Rudaz C, Dorfman M, Paredes A, Ojeda SR. NTRK1 and NTRK2 receptors facilitate follicle assembly and early follicular development in the mouse ovary. Reproduction 2009; 138:131-40.
34. Tamaru T, Okada M, Nakagawa H. Differential expression of D type cyclins during neuronal maturation. Neurosci Lett 1994; 168:229-32.
35. Zhao ZK, Jiang ZM, Liu XZ, Chen YT, Jia WJ. Study on reversion of malignant phenotype of glioma by siRNA targeting p75 neurotrophin receptor. Zhonghua Bing Li Xue Za Zhi 2010; 39:400-4.
36. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12.